PEDEVCO: SGK trust buys 147,070 common shares
PEDEVCO Corp. (PED) reports that The SGK 2018 Revocable Trust purchased 147,070 common shares on October 8, 2026, at $13 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PEDEVCO Corp. (PED) reports that The SGK 2018 Revocable Trust purchased 147,070 common shares on October 8, 2026, at $13 per share. Dr. Simon Kukes is the trust’s trustee; a footnote says the report is not an admission that he beneficially owns the trust shares except to the extent of his pecuniary interest. No Rule 10b5-1 plan is reported. A separate entry lists 150 shares held indirectly by his spouse.
Insights
Analyzing...
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1 | 147,070 | $13.00 | $1.91M |
| holding | Common Stock F2 | -- | -- | -- |
| holding | Common Stock F3 | -- | -- | -- |
Footnotes (3)
- F1. Shares held by The SGK 2018 Revocable Trust, of which Dr. Simon Kukes is the trustee. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F2. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.. Except to the extent of his pecuniary interest therein this report shall not be deemed an admission that Dr. Kukes is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
- F3. Shares held directly by Dr. Simon Kukes.
Key Figures
Key Terms
pecuniary interest regulatory
beneficial owner regulatory
trustee regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.